Ishii Yoshikazu

Affiliation and department：
Research theme for competitive and other funds (15)：

2022 - 2025 Development of novel cationitic antimicrobial peptides with D-amino acid against resipratory infection by drug-resistant bacteria
2021 - 2024 新規病原体核酸検査に用いる汎用的精度管理標品の迅速な作成を検証に資する研究
2020 - 2023 Elucidation of Clostridioides difficile transmission pattern based on One Health conception
2018 - 2021 Construction of the model for setting and verification of the clinical breakpoints of antibiotics
2017 - 2019 Carbapenem salvaging therapy for CRE infections

Show all

Papers (314)：

Kohji Komori, Kotaro Aoki, Sohei Harada, Yoshikazu Ishii, Kazuhiro Tateda. Plasmid-mediated acquisition and chromosomal integration of blaCTX-M-14 in a subclade of Escherichia coli ST131-H30 clade C1. Antimicrobial agents and chemotherapy. 2024. e0081724
Daisuke Ono, Anna Cmolik, Christopher R Bethel, Yoshikazu Ishii, Salvador I Drusin, Diego M Moreno, Alejandro J Vila, Robert A Bonomo, Maria F Mojica. The interaction of the azetidine thiazole side chain with the active site loop (ASL) 3 drives the evolution of IMP metallo-β-lactamase against tebipenem. Antimicrobial agents and chemotherapy. 2024. e0068724
Sohei Harada, Kotaro Aoki, Yusuke Nomura, Yuki Ohama, Hideki Araoka, Brian Hayama, Takayuki Sakurai, Akihiro Ueda, Yoshikazu Ishii, Takeya Tsutsumi. Transmission of global clones of NDM-producing Enterobacterales and interspecies spread of IncX3 plasmid harboring blaNDM-5 in Tokyo. Journal of global antimicrobial resistance. 2024
Ayako Shiozawa, Chiaki Kajiwara, Yoshikazu Ishii, Kazuhiro Tateda. Corrigendum to "N-acetyl-cysteine mediates protection against Mycobacterium avium through induction of human β-defensin-2" [Microb Infect 22 (10) (2020) 567-575]. Microbes and infection. 2024. 105388-105388
Yoshiyuki Sugishita, Rie Moriuchi, Yoshikazu Ishii. External quality assessment survey for SARS-CoV-2 nucleic acid amplification tests in clinical laboratories in Tokyo, 2021. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024. 30. 7. 633-641

ｍore...

MISC (233)：

野田和弘, 笠間敏博, 篠原満利恵, 濱田将風, 青木弘太郎, 松永行子, 高井まどか, 石井良和, 三宅亮. 薬剤耐性評価デバイス(Hollow Fiber Infection Model)の小型化. 化学とマイクロ・ナノシステム学会研究会講演要旨集(CD-ROM). 2023. 47th
荻原真二, 石井良和, 舘田一博. 環境除菌剤における持続抗菌作用の比較検討. 日本環境感染学会総会プログラム・抄録集. 2022. 37回. O51-3
山口哲央, 小野大輔, 濱田将風, 佐々木雅一, 村上日奈子, 大野秀明, 石井良和, 舘田一博. MRSAに対するβラクタム系抗菌薬のfosfomycin併用効果に関する検討. 日本化学療法学会雑誌. 2022. 70. Supplement-A
濱田将風, 石井良和, 舘田一博. 抗菌薬開発促進のためのHollow-Fiber Infection Modelに資する新規膜モジュールの開発. 日本感染症学会東日本地方会学術集会・日本化学療法学会東日本支部総会合同学会プログラム・抄録集. 2021. 70th-68th
吉澤定子, 吉澤定子, 吉澤定子, 小森光二, 澤友歌, 佐々木雅一, 青木弘太郎, 森伸晃, 石井良和, 舘田一博. 市中感染型クロストリディオイデス・ディフィシル感染症(CACDI)の伝播様式の解明. 日本感染症学会東日本地方会学術集会・日本化学療法学会東日本支部総会合同学会プログラム・抄録集. 2021. 70th-68th

ｍore...

Patents (5)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page